Two-Step Error-Controlling Classifiers With Application to Cost-Effective Disease Diagnosis.

Area of Science:

• Biomedical Science
• Decision Analysis
• Medical Diagnostics

Background:

• Accurate classification is crucial for clinical decision-making, especially in cancer diagnosis.
• Existing decision frameworks can be limited when classification performance is suboptimal.
• There's a need for methods that balance diagnostic accuracy with the cost of testing.

Purpose of the Study:

• To propose a novel family of two-step classifiers for selective biomarker testing.
• To optimize decision-making frameworks by incorporating a neutral zone for indeterminate cases.
• To minimize uncertainty in diagnostic procedures while managing testing costs.

Main Methods:

• Development of a two-step classification approach.
• Application of decision theory principles, expanding on the Neyman-Pearson Lemma.
• Selective utilization of costly biomarker testing for specific patient subsets.

Main Results:

• The proposed classifiers selectively use expensive biomarker tests for targeted individuals.
• The approach highlights the trade-off between biomarker costs and improved classification performance.
• Demonstrated utility in a prostate cancer diagnostic biomarker study.

Conclusions:

• The new two-step classifiers enhance decision-making in clinical scenarios like cancer diagnosis.
• Selective biomarker testing can improve accuracy and reduce uncertainty in diagnostic processes.
• This framework offers a cost-effective strategy for integrating biomarker data into clinical decisions.